These discoveries have greatly advanced the diagnosis of MPNs, and somatic mutations of JAK2, MPL and CALR are important criteria for the diagnosis of PMF, ET and PV according to the WHO/ICC classifications (3–6). This evidence concerns the gene CALR and essential thrombocythemia.